Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 533-539
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.533
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.533
Table 1 Clinical symptoms in the control and experimental groups before treatment n (%)
| Indices (clinical symptoms) | Control group (n = 30) | Experimental group (n = 90) | t/χ2 | P value |
| Stomach ache | 17 (56.67) | 50 (55.56) | 0.025 | 0.874 |
| Time to defecation (-x ± s) | 8.50 ± 1.31 | 8.71 ± 1.40 | -0.723 | 0.471 |
| Blood and pus | 10 (33.33) | 29 (32.22) | 0.028 | 0.867 |
| Tenesmus | 13 (43.33) | 38 (42.22) | 0.025 | 0.874 |
| Interleukin-8 (ng/L) | 25.83 ± 3.01 | 24.97 ± 2.98 | 1.366 | 0.175 |
- Citation: Zhao HY, Yang GT, Sun NN, Kong Y, Liu YF. Efficacy and safety of stellate ganglion block in chronic ulcerative colitis. World J Gastroenterol 2017; 23(3): 533-539
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/533.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.533